Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
A Sabin 3/Sabin 2/Sabin 3 (S3/2/3) intertypic recombinant poliovirus was isolated from a faecal specimen from a 2-year-old healthy boy approximately 12 weeks after administration of oral poliovirus vaccine. The first recombination junction was in the genomic region encoding the VP1 capsid protein between nucleotide positions 3274 and 3285 (numbering according to Sabin 3) and the second was in the RNA polymerase region (nucleotide positions 6824 and 6825). The recombination had introduced six Sabin 2-derived amino acids into the Sabin 3 capsid environment in the carboxyl terminus of VP1. The complete genome of the recombinant virus differed from corresponding parental Sabin strains at 33 nucleotide positions, nine of them resulting in an amino acid substitution. Four substitutions were in the capsid proteins and five were in the region encoding the non-structural proteins. One amino acid was changed in the antigenic site 2B and two in site 3B. In addition, the whole antigenic site 3A was replaced by Sabin 2-specific amino acids, but the antigenic characteristics of the S3/2/3 did not show type 2-specific features. Neutralizing antibody titres in sera from Finnish children immunized with the inactivated poliovirus vaccine were not lower against the recombinant virus than against Sabin 3. Our results suggest that the chimeric virus was most likely generated by recombination events in the vaccinee, rather than representing progeny of circulating vaccine-derived virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 4×
“An outbreak of poliomyelitis on the island of Hispaniola was associated with circulating type 1 vaccine-derived poliovirus (Kew et al. , 2002).”
InfluentialEvans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V. (1985) · Nature · doi:10.1038/314548a0 · Cited by 440 · cited 1×
“This substitution is found often in vaccine strains isolated from healthy vaccinees and VAPP cases, consistent with rapid reversion of this nucleotide in the human gut (Evans et al. , 1985; Minor & Dunn, 1988).”
Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202
Kilpatrick, D. R., Nottay, B., Yang, C. F., Yang, S. J., Mulders, M. N., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2990-2996.1996 · Cited by 172
Furlone, M., Guillot, S., Otelea, D., Balanant, J., Candrea, A., & Crainic, R. (1993) · Virology · doi:10.1006/viro.1993.1468 · Cited by 148 · cited 2×
“…that recombination is a frequent phenomenon in polio vaccinees, including strains isolated from cases of vaccine-associated paralytic poliomyelitis (VAPP) (e.g. Gammack et al. , 1989; Lipskaya et al. , 1991; Furione et al. , 1993; Georgescu et al. , 1994, 1995; Georgopoulou & Markoulatos, 2001).”
Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees
Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R., & Delpeyroux, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5740-5751.2001 · Cited by 136 · cited 2×
“Vaccine/vaccine and vaccine/non-vaccine recombinants have been described in many studies (e.g. Guillot et al. , 2000; Cuervo et al. , 2001).”
Macadam, A. J., Arnold, C., Howlett, J., John, A., Marsden, S., Taffs, F., Reeve, P., Hamada, N., Wareham, K., Almond, J., et al. (1989) · Virology · doi:10.1016/0042-6822(89)90183-9 · Cited by 125
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119 · cited 2×
“All these type 1 recombinants had a 367 nt block of sequence derived from Sabin 1 spanning 115 39-terminal nucleotides of the VP1 gene and the 59 half of the 2A gene in a wild-type poliovirus 1 environment ( Liu et al., 2000 ).”
Intertypic genomic rearrangements of poliovirus strains in vaccinees
CAMMACK, N., PHILLIPS, A., DUNN, G., PATEL, V, & MINOR, P. (1988) · Virology · doi:10.1016/s0042-6822(88)90113-4 · Cited by 111
Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97 · cited 2×
“…that recombination is a frequent phenomenon in polio vaccinees, including strains isolated from cases of vaccine-associated paralytic poliomyelitis (VAPP) (e.g. Gammack et al. , 1989; Lipskaya et al. , 1991; Furione et al. , 1993; Georgescu et al. , 1994, 1995; Georgopoulou & Markoulatos, 2001).”
Cited by
Oberste, M. S., Maher, K., & Pallansch, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.855-867.2004 · Cited by 260
Simmonds, P. (2006) · Journal of Virology · doi:10.1128/jvi.01076-06 · Cited by 204
“vaccinee contained a breakpoint at the conserved C terminus of VP1, leading to only four amino acid changes in VP1, none of which were serotype specific (6).”
BackgroundCalibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Recombination in circulating enteroviruses
Lukashev, A. N., Lashkevich, V. A., Ivanova, O. E., Koroleva, G. A., Hinkkanen, A. E., & Ilonen, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10423-10431.2003 · Cited by 170
Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Metadata
- Authors
- Blomqvist, S., Bruu, A.-L., Stenvik, M., & Hovi, T.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2003-03-01
- Volume
- 84
- Issue
- 3
- Pages
- 573-580
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2150905080
- Cited by
- 94
- References
- 12
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. https://app.cochat.ai/papers/10.1099/vir.0.18708-0
- The paper
- Blomqvist, S., Bruu, A.-L., Stenvik, M., & Hovi, T. (2003). Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. Journal of General Virology. https://doi.org/10.1099/vir.0.18708-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.